
Retmed Pharma Distribution Private Limited
About Retmed Pharma Distribution Private Limited
Data last updated:
Retmed Pharma Distribution Private Limited is a private limited company based in Palakkad, Kerala, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 25 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U51909KL2020PTC065957.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹41.5 Lakh. It is led by directors including Ponnath Sathyapalan and Thekkedath Ramakrishnan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4/463/3 Vinayaka Building Kannara Street, Palakkad, Kerala, India – 678001.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.08 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹1.29 Lakh (net margin 1.2%) and EBITDA of ₹2.02 Lakh (EBITDA margin 1.9%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Retmed Pharma Distribution Private Limited's registered office is in Palakkad, Kerala.
- Registered Address4/463/3 Vinayaka Building Kannara Street, Palakkad, Kerala, India – 678001
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Retmed Pharma Distribution is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Retmed Pharma Distribution Private Limited, buy the company report.
Financials of Retmed Pharma Distribution Private Limited
FY 2025 filings availableRetmed Pharma Distribution Private Limited reported revenue of ₹1.08 Cr (down 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 3% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 10%. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.02 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.29 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.9% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Retmed Pharma Distribution Private Limited, buy the company report.
Board of directors of Retmed Pharma Distribution Private Limited
Retmed Pharma Distribution has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ponnath Sathyapalan | Director | 25 Nov 2020 | 5 Years 11 Months | Current |
| Thekkedath Ramakrishnan | Director | 25 Nov 2020 | 5 Years 11 Months | Current |
| Vallikkad Unnikannan | Director | 25 Nov 2020 | 5 Years 11 Months | Current |
| Pallichedayath Dileepkumar | Director | 25 Nov 2020 | 5 Years 11 Months | Current |
Peer comparison
Retmed Pharma Distribution Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| JSC Ec Ues Private Limited | ₹1.08 Cr (FY 2020) | Hyderabad, Telangana, India | ||||
| Aquafills Traders Private Limited | ₹1.08 Cr (FY 2024) | -32.0% | Ghaziabad, Uttar Pradesh, India | |||
| Babashri Projects (India) Private Limited | ₹1.08 Cr (FY 2017) | 36.0% | Indore, Madhya Pradesh, India | |||
| Kanchan Marmo Grani Private Limited | ₹1.08 Cr (FY 2025) | -5.0% | Piparda, Rajasthan, India | |||
| Khushi Chemicals Private Limited | ₹1.08 Cr (FY 2025) | 1.0% | Ahmedabad, Gujarat, India | |||
| Retmed Pharma Distribution Private Limitedthis company | ₹1.08 Cr (FY 2025) | ₹1.29 Lakh | 1.2% | -3.0% | Palakkad, Kerala, India | |
| Beta Corporate Management Services Private Limited | ₹1.08 Cr (FY 2024) | 837.0% | Chennai, Tamil Nadu, India | |||
| Lumax Genuine Spares Private Limited | ₹1.08 Cr (FY 2023) | -87.0% | Delhi, India | |||
| Capricon Complex Private Limited | ₹1.08 Cr (FY 2023) | -21.0% | Kolkata, West Bengal, India | |||
| Biotique Agri Foods Private Limited | ₹1.08 Cr (FY 2025) | -40.0% | Jodhpur, Rajasthan, India | |||
| Noble Carbons Private Limited | ₹1.07 Cr (FY 2025) | 20.0% | Sangareddy, Telangana, India |
To see the full peer comparison of Retmed Pharma Distribution Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Retmed Pharma Distribution Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Retmed Pharma Distribution Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Retmed Pharma Distribution Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Retmed Pharma Distribution Private Limited has 4 board changes on record since 2020: 4 appointments. The latest: Pallichedayath Dileepkumar was appointed as Director on 25 Nov 2020.
Frequently asked questions
Retmed Pharma Distribution is an active private limited company based in Palakkad, Kerala, India. The company works in specialty, within the trading industry. It was incorporated on 25 November 2020 (6+ years old) and is registered under CIN U51909KL2020PTC065957.
Retmed Pharma Distribution has 4 current directors:
- Ponnath Sathyapalan - Director
- Thekkedath Ramakrishnan - Director
- Vallikkad Unnikannan - Director
- Pallichedayath Dileepkumar - Director
The latest financial statements of Retmed Pharma Distribution on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Retmed Pharma Distribution is U51909KL2020PTC065957. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Retmed Pharma Distribution was incorporated on 25 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Retmed Pharma Distribution by revenue are JSC Ec Ues Private Limited, Aquafills Traders Private Limited, Babashri Projects (India) Private Limited, Kanchan Marmo Grani Private Limited, Khushi Chemicals Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Pallichedayath Dileepkumar was appointed as Director on 25 Nov 2020. Ponnath Sathyapalan was appointed as Director on 25 Nov 2020. Thekkedath Ramakrishnan was appointed as Director on 25 Nov 2020. Retmed Pharma Distribution has 4 board changes on record in total.
The registered office of Retmed Pharma Distribution is at 44633 Vinayaka Building Kannara Street, Palakkad, Kerala, India – 678001.
Retmed Pharma Distribution operates in the trading industry, in the specialty segment.
The compliance status of Retmed Pharma Distribution is compliant as of 16 August 2026. The company is actively filing with the Registrar of Companies.
Retmed Pharma Distribution can be reached at its registered office: 44633 Vinayaka Building Kannara Street, Palakkad, Kerala, India – 678001.